Acer Therapeutics Inc. (40)

Browse by Contract Category

Contracts

Securities Purchase Agreement, dated November 29, 2022, by and between Acer Therapeutics Inc. and the investors listed on Schedule I thereto (Filed With SEC on November 30, 2022)
Employment Agreement between Acer Therapeutics Inc. and Tanya Hayden dated June 19, 2022 (Filed With SEC on June 21, 2022)
Synthetic Royalty Agreement dated March 4, 2022, between Acer Therapeutics Inc., MAM Aardvark, LLC and Marathon Healthcare Finance Fund, L.P (Filed With SEC on March 7, 2022)
Lease Agreement, dated October 15, 2021, by and between Acer Therapeutics Inc. and Commonwealth Development LLC, as trustee of the Gateway Realty Trust (Filed With SEC on March 2, 2022)
Exclusive License Agreement, dated as of April 4, 2014, by and between Acer Therapeutics Inc. and Baylor College of Medicine (Filed With SEC on May 17, 2021)
Collaboration and License Agreement, dated March 19, 2021, by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AG (Filed With SEC on March 22, 2021)
Warrant issued on August 19, 2022, by the Company to SWK Funding LLC pursuant to the Amendment to Credit Agreement dated August 19, 2022, among Acer Therapeutics Inc., the lenders... (Filed With SEC on August 23, 2022)
Amendment to Credit Agreement dated August 19, 2022, among Acer Therapeutics Inc., the lenders party thereto and SWK Funding LLC, as the agent, sole lead arranger and sole... (Filed With SEC on August 23, 2022)
Warrant issued on March 4, 2022, by the Company to SWK Funding LLC pursuant to the Credit Agreement dated March 4, 2022, among Acer Therapeutics Inc., the lenders party thereto... (Filed With SEC on March 7, 2022)
Credit Agreement dated March 4, 2022, among Acer Therapeutics Inc., the lenders party thereto and SWK Funding LLC, as the agent, sole lead arranger and sole bookrunner (Filed With SEC on March 7, 2022)
Guarantee and Collateral Agreement dated March 4, 2022, among Acer Therapeutics Inc. and SWK Funding LLC, as agent (Filed With SEC on March 7, 2022)
Secured Convertible Note Purchase Agreement dated March 4, 2022, between Acer Therapeutics Inc., MAM Aardvark, LLC and Marathon Healthcare Finance Fund, L.P (Filed With SEC on March 7, 2022)
Form of Secured Convertible Note issuable by Acer Therapeutics Inc. to MAM Aardvark, LLC and Marathon Healthcare Finance Fund, L.P. pursuant to the Secured Convertible Note... (Filed With SEC on March 7, 2022)
Credit Agreement dated March 4, 2022, among Acer Therapeutics Inc., the lenders party thereto and MAM Aardvark, LLC, as the agent, sole lead arranger and sole bookrunner (Filed With SEC on March 7, 2022)
Form of Guarantee and Collateral Agreement to be dated the Term Loan Funding Date among Acer Therapeutics Inc. and MAM Aardvark, LLC, as agent (Filed With SEC on March 7, 2022)
Second Amendment, dated November 17, 2021, by and between Acer Therapeutics Inc. and Eastern Western Corp (Filed With SEC on March 2, 2022)
Employment Agreement, dated January 14, 2022, by and between Acer Therapeutics Inc. and Bernie Paul (Filed With SEC on March 2, 2022)
Notice of Stock Option Grant (Inducement Award) and Stock Option Agreement (Inducement Award), dated February 21, 2022, between Acer Therapeutics Inc. and Adrian W. Quartel for... (Filed With SEC on February 22, 2022)
Employment Agreement, dated February 21, 2022, between Acer Therapeutics Inc. and Adrian W. Quartel (Filed With SEC on February 22, 2022)
Acer Therapeutics Inc. 2018 Stock Incentive Plan, as amended and restated (Filed With SEC on February 22, 2022)
Waiver and Agreement, dated October 6, 2021, by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AG (Filed With SEC on October 8, 2021)
First Amendment, dated April 23, 2019, by and between Acer Therapeutics Inc. and Eastern Western Corp (Filed With SEC on August 10, 2021)
Agreement of Access and Use of Clinical Trial Data, dated as of August 3, 2016, by and between LAssistance Publique Hpitaux de Paris and Acer Therapeutics Inc (Filed With SEC on August 10, 2021)
Employment Agreement, dated February 1, 2021, by and between Acer Therapeutics Inc. and Jefferson E. Davis (Filed With SEC on March 1, 2021)
Form of Notice of Stock Option Grant and Stock Option Agreement for option awards to be made under the 2018 Stock Incentive Plan (Filed With SEC on March 1, 2021)
Security Agreement, dated January 25, 2021, by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AG (Filed With SEC on January 25, 2021)
Promissory Note, dated January 25, 2021, issued by Acer Therapeutics Inc. in favor of Relief Therapeutics Holding AG (Filed With SEC on January 25, 2021)
Option Agreement, dated January 25, 2021, by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AG (Filed With SEC on January 25, 2021)
Exclusive License Agreement, dated as of December 21, 2018, by and between Acer Therapeutics Inc. and Sanofi (Filed With SEC on August 13, 2020)
Securities Purchase Agreement, dated July 24, 2020, by and between Acer Therapeutics Inc. and the investors listed on Schedule I thereto (Filed With SEC on July 27, 2020)
Research Collaboration Agreement, dated March 26, 2020, by and between Acer Therapeutics Inc. and the National Center for Advancing Translational Sciences (Filed With SEC on June 1, 2020)
Registration Rights Agreement, dated as of April 30, 2020 by and between Acer Therapeutics Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 30, 2020)
Purchase Agreement, dated as of April 30, 2020 by and between Acer Therapeutics Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 30, 2020)
Amended and Restated Sales Agreement, dated March 18, 2020 by and among Acer Therapeutics Inc., Roth Capital Partners, LLC, and JonesTrading Institutional Services LLC (Filed With SEC on March 18, 2020)
Description of the Companys capital stock registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 18, 2020)
Employment agreement, dated September 18, 2019, by and between Acer Therapeutics Inc. and Matthew T. Seibt (Filed With SEC on November 13, 2019)
Employment agreement, dated September 18, 2019, by and between Acer Therapeutics Inc. and John Klopp (Filed With SEC on November 13, 2019)
Lease Agreement, dated March 5, 2019, by and between Acer Therapeutics Inc. and Commonwealth Development LLC, as a trustee of the Gateway Realty Trust (Filed With SEC on August 13, 2019)
Employment Agreement, dated December 4, 2018, by and between Acer Therapeutics Inc. and Salma Jutt-Eghbali (Filed With SEC on March 7, 2019)
Form of Notice of Restricted Stock Award for awards under the 2018 Stock Incentive Plan (Filed With SEC on March 7, 2019)